STAAR Surgical Company STAA
NASDAQ
| 10/02/2026 | 07/03/2026 | 04/03/2026 | 01/02/2026 | 09/26/2025 | |
|---|---|---|---|---|---|
| Revenue | -11.95% | 111.04% | 119.59% | 18.08% | 6.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.95% | 111.04% | 119.59% | 18.08% | 6.93% |
| Cost of Revenue | 44.01% | 106.65% | 69.11% | -18.74% | -16.15% |
| Gross Profit | -24.06% | 112.59% | 145.88% | 38.21% | 13.71% |
| SG&A Expenses | -2.33% | 5.11% | -19.27% | -8.69% | -12.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.88% | 20.84% | -1.59% | -10.54% | -15.22% |
| Operating Income | -77.39% | 141.30% | 150.40% | 60.84% | 326.08% |
| Income Before Tax | -62.85% | 142.54% | 115.08% | 31.92% | 42.79% |
| Income Tax Expenses | -85.82% | 132.58% | 1,195.27% | -160.17% | 211.61% |
| Earnings from Continuing Operations | -37.25% | 147.93% | 109.60% | 46.51% | -10.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.25% | 147.93% | 109.60% | 46.51% | -10.98% |
| EBIT | -77.39% | 141.30% | 150.40% | 60.84% | 326.08% |
| EBITDA | -69.91% | 155.43% | 160.56% | 65.06% | 253.01% |
| EPS Basic | -38.38% | 147.16% | 109.49% | 47.04% | -11.74% |
| Normalized Basic EPS | -72.30% | 152.49% | 154.80% | 71.44% | 86.36% |
| EPS Diluted | -38.55% | 147.06% | 109.09% | 47.04% | -10.50% |
| Normalized Diluted EPS | -72.28% | 151.30% | 153.73% | 71.44% | 84.95% |
| Average Basic Shares Outstanding | 1.83% | 1.62% | 1.14% | 1.00% | 0.88% |
| Average Diluted Shares Outstanding | 1.78% | 4.00% | 3.15% | 1.00% | 1.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |